Back

Single-center experience with quinidine for patients with electrical storm due to ventricular arrhythmias associated with short-coupled premature ventricular contractions

31 March 2025 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias management Drug Treatment of Ventricular Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Martin Negreira-Caamano

University Hospital Getafe, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Electroanatomical differences in ajmaline-induced compared to spontaneous type-1 Brugada phenotype
Doctor S. Latrofa (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Repolarization and depolarization abnormalities are preferentially impaired by ajmaline in Brugada patients compared to controls
Doctor A. Rossi (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Electrical storm in patients with hypertrophic cardiomyopathy
Doctor P. Groussin (FR)
Abstract Slides Video
Presentation thumbnail
Three-dimensional characterization of ventricular arrhythmias in structural heart disease with a novel digital twin framework.
Doctor M. Parollo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
A hybrid score to predict the origin of outflow tract ventricular arrhythmias in patients with intraventricular conduction disorders or paced rhythm
Doctor G. Falasconi (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular arrhythmias management

The Event

Event poster

EHRA 2025

31 March 2025 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Intravenous phenytoin in arrhythmic storm due to short-coupled idiopathic ventricular fibrillation
thumbnail
Congress Presentation
Why, when, and for whom should we use quinidine?
thumbnail
Congress Presentation
Taming the electrical storm: quinidine's success in refractory short-coupled IVF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources